+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Small effects of valproic acid on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenic or affective disorders



Small effects of valproic acid on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenic or affective disorders



Therapeutic Drug Monitoring 21(3): 341-345



Two separate studies were carried out to assess the effect of valproic acid on the steady-state plasma concentrations of clozapine and its major metabolites nor-clozapine and clozapine N-oxide in psychotic patients. In the first study, concentrations of clozapine and metabolites were compared between patients treated with clozapine in combination with sodium valproate (n = 15) and control patients treated with clozapine alone (n = 22) and matched for sex, age, body weight, and antipsychotic dosage. Patients comedicated with valproate tended to have higher clozapine levels and lower norclozapine levels, but the differences did not reach statistical significance. In a subsequent study, plasma concentrations of clozapine and its metabolites were determined in 6 patients with schizophrenia stabilized on clozapine therapy (200-400 mg/d) before and after treatment with sodium valproate (900-1200 mg/d) for 4 weeks. Mean plasma concentrations of clozapine and its metabolites did not change significantly throughout the study, but there was a trend for clozapine levels to be higher and for norclozapine levels to be lower after valproate. Overall, these findings suggest that valproic acid may have an inhibiting effect on the CYP1A2- or CYP3A4-mediated conversion of clozapine to norclozapine. However, the interaction is unlikely to be clinically significant.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 011369314

Download citation: RISBibTeXText

PMID: 10365650


Related references

Effect of valproic acid on behavior and plasma amino acid concentrations in chronic schizophrenic patients. Biological Psychiatry 20(2): 209-215, 1985

Effect of fluoxetine on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenia. International Clinical Psychopharmacology 13(3): 141-145, 1998

P-4-47 Effects of clozapine on plasma monoamine metabolites in treatment-refractory schizophrenic patients. European Neuropsychopharmacology 5(3): 341-342, 1995

Interaction of valproic acid and antidepressants on clozapine metabolism in affective patients. European Neuropsychopharmacology 29: S320-S321, 2019

Valproic acid concentrations in plasma plasma ultra filtrate and cerebro spinal fluid in patients with convulsive disorders. Folia Psychiatrica et Neurologica Japonica 36(3): 343, 1982

Clozapine and metabolites plasma levels in resistant schizophrenic patients. Journal de Pharmacie Clinique 18(3): 244-250, 1999

5 doubly unsaturated metabolites of valproic acid in urine and plasma of patients on valproic acid therapy. Journal of Clinical Chemistry & Clinical Biochemistry 22(4): 309-318, 1984

Five doubly unsaturated metabolites of valproic acid in urine and plasma of patients on valproic acid therapy. Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift für Klinische Chemie und Klinische Biochemie 22(4): 309-317, 1984

Gender differences in plasma clozapine levels and its metabolites in schizophrenic patients. Human Psychopharmacology. 12(5): 489-495,.-., 1997

Monitoring of plasma clozapine levels and its metabolites in refractory schizophrenic patients. Therapeutic Drug Monitoring 18(2): 200-207, 1996

Plasma concentrations of clozapine and its major metabolites during combined treatment with paroxetine or sertraline. Pharmacopsychiatry 33(6): 213-217, 2001

Valproic acid effects on serum concentrations of clozapine and norclozapine. American Journal of Psychiatry 152(4): 650, 1995

Lack of effect of grapefruit juice and ketoconazole on the pharmacokinetics of clozapine and its major metabolites in schizophrenic patients. Pharmacotherapy 20(10): 1267, 2000

Concentrations in plasma clozapine levels in schizophrenic and schizoaffective patients. Revista de Psiquiatria Y Salud Mental 10(4): 192-196, 2017

Clozapine and norclozapine concentrations in serum and plasma samples from schizophrenic patients. Therapeutic Drug Monitoring 30(1): 41-45, 2008